See A Difference with Upneeq®
Upneeq is the only FDA-approved once-daily prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes
Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is indicated for the treatment of acquired blepharoptosis in adults
In clinical trials, Upneeq helped patients with acquired ptosis see more—on the first day of treatment! 87.8% of patients had some form of improvement 40.8% of patients had at least a 50% improvement on Day 14 (2 hours after applying Upneeq)
Upneeq is a non-surgical minimally invasive eyelift alternative.
While you won’t get the more dramatic results you can expect from eyelid lift surgery, patients see an average of about 1 mm of lift in their upper eyelid after the first use—just enough to make a noticeable difference.
